English

GAMMA BIOLOGICALS INC

EDGAR

Quarterly report (10-Q) · filed 1998-08-14

14 filing records in this dataset, filed from 1995-06-29 to 1998-08-14. Explore the available filing history and original sources.

Inspect reported changes Compare with another company Historical disclosures Search filings Segments

Watchlist

Latest quarter

Revenue

4.37 million USD

1998-06-30 · USD

Exact inputs and evidence

Revenue: 4366544 USD Source

Operating margin

-6.72%

1998-06-30 · %

Exact inputs and evidence

Operating Income: -293514 USD Source
Revenue: 4366544 USD Source

Operating cash flow

530 thousand USD

1998-06-30 · USD

Exact inputs and evidence

Operating Cash Flow: 530222 USD Source

Free cash flow

118 thousand USD

1998-06-30 · USD

Exact inputs and evidence

Operating Cash Flow: 530222 USD Source
Capital Expenditure: 412470 USD Source

Cash and cash equivalents: 1.31 million USD 1998-06-30 Source
Exact value

1312797 USD
Long-term debt including current maturities: Not available
Shares outstanding: Not available

Trailing twelve months

The four most recent complete quarters added together. This gives a full-year view that includes the latest quarterly results.

Net income

844 thousand USD

1997-07-01 – 1998-06-30

Exact inputs and evidence

Net income: 321003 USD · 1997-07-01 – 1997-09-30 Source
Net income: 518121 USD · 1997-10-01 – 1997-12-31 Source
Net income: 1309616 USD · 1997-04-01 – 1998-03-31 Source
Net income: 1148130 USD · 1997-04-01 – 1997-12-31 Source
Net income: -156902 USD · 1998-04-01 – 1998-06-30 Source

Operating cash flow

557 thousand USD

1997-07-01 – 1998-06-30

Exact inputs and evidence

Operating cash flow: 381758 USD · 1997-04-01 – 1997-09-30 Source
Operating cash flow: 245 USD · 1997-04-01 – 1997-06-30 Source
Operating cash flow: 573416 USD · 1997-04-01 – 1997-12-31 Source
Operating cash flow: 381758 USD · 1997-04-01 – 1997-09-30 Source
Operating cash flow: 27393 USD · 1997-04-01 – 1998-03-31 Source
Operating cash flow: 573416 USD · 1997-04-01 – 1997-12-31 Source
Operating cash flow: 530222 USD · 1998-04-01 – 1998-06-30 Source

Capital expenditure

2.83 million USD

1997-07-01 – 1998-06-30

Exact inputs and evidence

Capital expenditure: 728882 USD · 1997-04-01 – 1997-09-30 Source
Capital expenditure: 431869 USD · 1997-04-01 – 1997-06-30 Source
Capital expenditure: 1870485 USD · 1997-04-01 – 1997-12-31 Source
Capital expenditure: 728882 USD · 1997-04-01 – 1997-09-30 Source
Capital expenditure: 2853738 USD · 1997-04-01 – 1998-03-31 Source
Capital expenditure: 1870485 USD · 1997-04-01 – 1997-12-31 Source
Capital expenditure: 412470 USD · 1998-04-01 – 1998-06-30 Source

Free cash flow

-2.28 million USD

1997-07-01 – 1998-06-30

Exact inputs and evidence

Operating cash flow: 381758 USD · 1997-04-01 – 1997-09-30 Source
Operating cash flow: 245 USD · 1997-04-01 – 1997-06-30 Source
Operating cash flow: 573416 USD · 1997-04-01 – 1997-12-31 Source
Operating cash flow: 381758 USD · 1997-04-01 – 1997-09-30 Source
Operating cash flow: 27393 USD · 1997-04-01 – 1998-03-31 Source
Operating cash flow: 573416 USD · 1997-04-01 – 1997-12-31 Source
Operating cash flow: 530222 USD · 1998-04-01 – 1998-06-30 Source
Capital expenditure: 728882 USD · 1997-04-01 – 1997-09-30 Source
Capital expenditure: 431869 USD · 1997-04-01 – 1997-06-30 Source
Capital expenditure: 1870485 USD · 1997-04-01 – 1997-12-31 Source
Capital expenditure: 728882 USD · 1997-04-01 – 1997-09-30 Source
Capital expenditure: 2853738 USD · 1997-04-01 – 1998-03-31 Source
Capital expenditure: 1870485 USD · 1997-04-01 – 1997-12-31 Source
Capital expenditure: 412470 USD · 1998-04-01 – 1998-06-30 Source

Includes later revisions to earlier periods. Annual charts exclude incomplete years.

Latest filing recorded: 1998-08-14.

Financial data available through: 1997-03-31.

Coverage by financial measure

Revenue: 5 of 11 periods available· newest 1997-03-31
Operating income: 5 of 11 periods available· newest 1997-03-31
Net income: 5 of 11 periods available· newest 1997-03-31
Operating cash flow: 5 of 11 periods available· newest 1997-03-31
Capital expenditure: 5 of 11 periods available· newest 1997-03-31
Total assets: 4 of 11 periods available· newest 1997-03-31
liabilities: No compatible figures in this window
Current assets: 4 of 11 periods available· newest 1997-03-31
Current liabilities: 4 of 11 periods available· newest 1997-03-31
Cash and cash equivalents: 5 of 11 periods available· newest 1997-03-31
long term debt: No compatible figures in this window
shares outstanding: No compatible figures in this window

Coverage describes values retained in this snapshot. Missing values are not zero; loading limits are reported separately.

What changed year over year

Latest complete year compared with the corresponding period one year earlier. These are measured changes; they do not establish their business causes.

Revenue
+3.6%

Prior period

USD 16.94 million

1995-04-01 – 1996-03-31
Current period

USD 17.55 million

1996-04-01 – 1997-03-31

Exact inputs and evidence

17554502 − 16940588 = 613914 USD

16940588 USD · 1995-04-01 – 1996-03-31
Inspect prior input Prior source
17554502 USD · 1996-04-01 – 1997-03-31
Inspect current input Current source

Share or cite

Citation for Year-over-year change in Revenue · GAMMA BIOLOGICALS INC · 1997-03-31 GAMMA BIOLOGICALS INC (edgar:317890) Year-over-year change in Revenue: 613914 USD Concept: fundies:Revenue Period: 1996-04-01 to 1997-03-31 Values: Latest reported Published: 2026-11-06T13:21:10Z Snapshot: c1c1c7a2e9c234c9f8eeddae5dc416c4f05ba55f551639e1bb89a8556b1eaaa8 Dimensions: Consolidated View: https://fundies.io/companies/edgar/317890?view=overview&cadence=annual&surface=latest#period-changes-title Computed: Current period minus corresponding prior-year period Input fundies:Revenue: 17554502 USD (1996-04-01 to 1997-03-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/317890/0000899243-97-001217.txt#4593 Input fundies:Revenue: 16940588 USD (1995-04-01 to 1996-03-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/317890/0000899243-97-001217.txt#4593
The citation records this snapshot. The page link may show a newer release later.
Net income
+35.5%

Prior period

USD 823,530

1995-04-01 – 1996-03-31
Current period

USD 1.12 million

1996-04-01 – 1997-03-31

Exact inputs and evidence

1115820 − 823530 = 292290 USD

823530 USD · 1995-04-01 – 1996-03-31
Inspect prior input Prior source
1115820 USD · 1996-04-01 – 1997-03-31
Inspect current input Current source

Share or cite

Citation for Year-over-year change in Net income · GAMMA BIOLOGICALS INC · 1997-03-31 GAMMA BIOLOGICALS INC (edgar:317890) Year-over-year change in Net income: 292290 USD Concept: fundies:NetIncome Period: 1996-04-01 to 1997-03-31 Values: Latest reported Published: 2026-11-06T13:21:10Z Snapshot: c1c1c7a2e9c234c9f8eeddae5dc416c4f05ba55f551639e1bb89a8556b1eaaa8 Dimensions: Consolidated View: https://fundies.io/companies/edgar/317890?view=overview&cadence=annual&surface=latest#period-changes-title Computed: Current period minus corresponding prior-year period Input fundies:NetIncome: 1115820 USD (1996-04-01 to 1997-03-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/317890/0001047469-98-025756.txt#2202 Input fundies:NetIncome: 823530 USD (1995-04-01 to 1996-03-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/317890/0001047469-98-025756.txt#2202
The citation records this snapshot. The page link may show a newer release later.
Operating cash flow
-4.9%

Prior period

USD 2.15 million

1995-04-01 – 1996-03-31
Current period

USD 2.05 million

1996-04-01 – 1997-03-31

Exact inputs and evidence

2047116 − 2152105 = -104989 USD

2152105 USD · 1995-04-01 – 1996-03-31
Inspect prior input Prior source
2047116 USD · 1996-04-01 – 1997-03-31
Inspect current input Current source

Share or cite

Citation for Year-over-year change in Operating cash flow · GAMMA BIOLOGICALS INC · 1997-03-31 GAMMA BIOLOGICALS INC (edgar:317890) Year-over-year change in Operating cash flow: -104989 USD Concept: fundies:OperatingCashFlow Period: 1996-04-01 to 1997-03-31 Values: Latest reported Published: 2026-11-06T13:21:10Z Snapshot: c1c1c7a2e9c234c9f8eeddae5dc416c4f05ba55f551639e1bb89a8556b1eaaa8 Dimensions: Consolidated View: https://fundies.io/companies/edgar/317890?view=overview&cadence=annual&surface=latest#period-changes-title Computed: Current period minus corresponding prior-year period Input fundies:OperatingCashFlow: 2047116 USD (1996-04-01 to 1997-03-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/317890/0001047469-98-025756.txt#2212 Input fundies:OperatingCashFlow: 2152105 USD (1995-04-01 to 1996-03-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/317890/0001047469-98-025756.txt#2212
The citation records this snapshot. The page link may show a newer release later.
Capital expenditure
-3.5%

Prior period

USD 1.67 million

1995-04-01 – 1996-03-31
Current period

USD 1.61 million

1996-04-01 – 1997-03-31

Exact inputs and evidence

1609727 − 1668145 = -58418 USD

1668145 USD · 1995-04-01 – 1996-03-31
Inspect prior input Prior source
1609727 USD · 1996-04-01 – 1997-03-31
Inspect current input Current source

Share or cite

Citation for Year-over-year change in Capital expenditure · GAMMA BIOLOGICALS INC · 1997-03-31 GAMMA BIOLOGICALS INC (edgar:317890) Year-over-year change in Capital expenditure: -58418 USD Concept: fundies:CapitalExpenditure Period: 1996-04-01 to 1997-03-31 Values: Latest reported Published: 2026-11-06T13:21:10Z Snapshot: c1c1c7a2e9c234c9f8eeddae5dc416c4f05ba55f551639e1bb89a8556b1eaaa8 Dimensions: Consolidated View: https://fundies.io/companies/edgar/317890?view=overview&cadence=annual&surface=latest#period-changes-title Computed: Current period minus corresponding prior-year period Input fundies:CapitalExpenditure: 1609727 USD (1996-04-01 to 1997-03-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/317890/0001047469-98-025756.txt#2172 Input fundies:CapitalExpenditure: 1668145 USD (1995-04-01 to 1996-03-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/317890/0001047469-98-025756.txt#2172
The citation records this snapshot. The page link may show a newer release later.

Where revenue goes

How a period’s revenue divides into costs and what remains as profit. Items marked Derived are calculated by subtraction from reported figures.

1997 1996-04-01 – 1997-03-31

Revenue USD 17.55 million 100% of revenue
Cost of revenue USD 7.86 million 45% of revenue
Operating expenses USD 8.12 million 46% of revenue
Operating income USD 1.58 million 9% of revenue
Tax, interest and other Derived USD 460,435 2.6% of revenue
Net income USD 1.12 million 6.4% of revenue

Cash

Operating cash flow USD 2.05 million 12% of revenue
Capital expenditure USD 1.61 million 9.2% of revenue
Free cash flow Derived USD 437,389 2.5% of revenue

Share of revenue by period

Net income
Tax, interest and other
Operating costs

1993 Operating loss: operating costs were 106% of revenue.
1994 91%
1995 88%
1996 95%
1997 91%

Values and sources

Revenue breakdown by annual reporting period
Period	Revenue	Operating costs	Operating income	Tax, interest and other	Net income	Free cash flow	Source
1993 1992-04-01 – 1993-03-31	16389848	17355510 Derived	-965662	-61268 Derived	-904394	776836 Derived	Source 1992-04-01 – 1993-03-31: 16389848 USD Inspect Revenue Open source 1992-04-01 – 1993-03-31: -965662 USD Inspect Operating Income Open source 1992-04-01 – 1993-03-31: -904394 USD Inspect Net Income Open source 1992-04-01 – 1993-03-31: 1048508 USD Inspect Operating Cash Flow Open source 1992-04-01 – 1993-03-31: 271672 USD Inspect Capital Expenditure Open source
1994 1993-04-01 – 1994-03-31	17212635	15666275 Derived	1546360	197812 Derived	1348548	2075341 Derived	Source 1993-04-01 – 1994-03-31: 17212635 USD Inspect Revenue Open source 1993-04-01 – 1994-03-31: 1546360 USD Inspect Operating Income Open source 1993-04-01 – 1994-03-31: 1348548 USD Inspect Net Income Open source 1993-04-01 – 1994-03-31: 2453912 USD Inspect Operating Cash Flow Open source 1993-04-01 – 1994-03-31: 378571 USD Inspect Capital Expenditure Open source
1995 1994-04-01 – 1995-03-31	18261288	16067988 Derived	2193300	726781 Derived	1466519	-532616 Derived	Source 1994-04-01 – 1995-03-31: 18261288 USD Inspect Revenue Open source 1994-04-01 – 1995-03-31: 2193300 USD Inspect Operating Income Open source 1994-04-01 – 1995-03-31: 1466519 USD Inspect Net Income Open source 1994-04-01 – 1995-03-31: 770013 USD Inspect Operating Cash Flow Open source 1994-04-01 – 1995-03-31: 1302629 USD Inspect Capital Expenditure Open source
1996 1995-04-01 – 1996-03-31	16940588	16041614 Derived	898974	75444 Derived	823530	483960 Derived	Source 1995-04-01 – 1996-03-31: 16940588 USD Inspect Revenue Open source 1995-04-01 – 1996-03-31: 898974 USD Inspect Operating Income Open source 1995-04-01 – 1996-03-31: 823530 USD Inspect Net Income Open source 1995-04-01 – 1996-03-31: 2152105 USD Inspect Operating Cash Flow Open source 1995-04-01 – 1996-03-31: 1668145 USD Inspect Capital Expenditure Open source
1997 1996-04-01 – 1997-03-31	17554502	15978247 Derived	1576255	460435 Derived	1115820	437389 Derived	Source 1996-04-01 – 1997-03-31: 17554502 USD Inspect Revenue Open source 1996-04-01 – 1997-03-31: 1576255 USD Inspect Operating Income Open source 1996-04-01 – 1997-03-31: 1115820 USD Inspect Net Income Open source 1996-04-01 – 1997-03-31: 2047116 USD Inspect Operating Cash Flow Open source 1996-04-01 – 1997-03-31: 1609727 USD Inspect Capital Expenditure Open source

Amounts are exact, in USD.

Growth

Sales over time and how quickly they are changing.

Revenue

Revenue reported for each complete financial period.

USD 17.6M 1997

Values and sources

Revenue values and source evidence
Period	Series	Value(USD)	Source evidence
19931993-03-31	Revenue	16389848	Revenue: 16389848 Open source
19941994-03-31	Revenue	17212635	Revenue: 17212635 Open source
19951995-03-31	Revenue	18261288	Revenue: 18261288 Open source
19961996-03-31	Revenue	16940588	Revenue: 16940588 Open source
19971997-03-31	Revenue	17554502	Revenue: 17554502 Open source

Revenue growth

Change in revenue from the same financial period one year earlier.

3.6% 1997

Values and sources

Revenue growth values and source evidence
Period	Series	Value	Source evidence
19931993-03-31	Year over year	No prior comparable period	Revenue: 16389848 Open source
19941994-03-31	Year over year	5%	Revenue: 17212635 Open source Revenue: 16389848 Open source
19951995-03-31	Year over year	6.1%	Revenue: 18261288 Open source Revenue: 17212635 Open source
19961996-03-31	Year over year	-7.2%	Revenue: 16940588 Open source Revenue: 18261288 Open source
19971997-03-31	Year over year	3.6%	Revenue: 17554502 Open source Revenue: 16940588 Open source

Profit and cash

How much revenue becomes profit, and how much cash operations generate.

Profit margins

Operating income, net income and free cash flow as a share of revenue.

Operating margin 9% 1997

Net margin 6.4% 1997

Free cash flow margin 2.5% 1997

Operating margin
Net margin
Free cash flow margin

Values and sources

Profit margins values and source evidence
Period	Series	Value	Source evidence
19931993-03-31	Operating margin	-5.9%	Operating Income: -965662 Open source Revenue: 16389848 Open source
19941994-03-31	Operating margin	9%	Operating Income: 1546360 Open source Revenue: 17212635 Open source
19951995-03-31	Operating margin	12%	Operating Income: 2193300 Open source Revenue: 18261288 Open source
19961996-03-31	Operating margin	5.3%	Operating Income: 898974 Open source Revenue: 16940588 Open source
19971997-03-31	Operating margin	9%	Operating Income: 1576255 Open source Revenue: 17554502 Open source
19931993-03-31	Net margin	-5.5%	Net Income: -904394 Open source Revenue: 16389848 Open source
19941994-03-31	Net margin	7.8%	Net Income: 1348548 Open source Revenue: 17212635 Open source
19951995-03-31	Net margin	8%	Net Income: 1466519 Open source Revenue: 18261288 Open source
19961996-03-31	Net margin	4.9%	Net Income: 823530 Open source Revenue: 16940588 Open source
19971997-03-31	Net margin	6.4%	Net Income: 1115820 Open source Revenue: 17554502 Open source
19931993-03-31	Free cash flow margin	4.7%	Revenue: 16389848 Open source Operating Cash Flow: 1048508 Open source Capital Expenditure: 271672 Open source
19941994-03-31	Free cash flow margin	12.1%	Revenue: 17212635 Open source Operating Cash Flow: 2453912 Open source Capital Expenditure: 378571 Open source
19951995-03-31	Free cash flow margin	-2.9%	Revenue: 18261288 Open source Operating Cash Flow: 770013 Open source Capital Expenditure: 1302629 Open source
19961996-03-31	Free cash flow margin	2.9%	Revenue: 16940588 Open source Operating Cash Flow: 2152105 Open source Capital Expenditure: 1668145 Open source
19971997-03-31	Free cash flow margin	2.5%	Revenue: 17554502 Open source Operating Cash Flow: 2047116 Open source Capital Expenditure: 1609727 Open source

Operating cash flow

Cash generated by the company’s normal business operations.

USD 2M 1997

Values and sources

Operating cash flow values and source evidence
Period	Series	Value(USD)	Source evidence
19931993-03-31	Operating cash flow	1048508	Operating Cash Flow: 1048508 Open source
19941994-03-31	Operating cash flow	2453912	Operating Cash Flow: 2453912 Open source
19951995-03-31	Operating cash flow	770013	Operating Cash Flow: 770013 Open source
19961996-03-31	Operating cash flow	2152105	Operating Cash Flow: 2152105 Open source
19971997-03-31	Operating cash flow	2047116	Operating Cash Flow: 2047116 Open source

Free cash flow

Operating cash flow minus capital expenditure for the same period and unit.

USD 437.4K 1997

Values and sources

Free cash flow values and source evidence
Period	Series	Value(USD)	Source evidence
19931993-03-31	Free cash flow	776836	Operating Cash Flow: 1048508 Open source Capital Expenditure: 271672 Open source
19941994-03-31	Free cash flow	2075341	Operating Cash Flow: 2453912 Open source Capital Expenditure: 378571 Open source
19951995-03-31	Free cash flow	-532616	Operating Cash Flow: 770013 Open source Capital Expenditure: 1302629 Open source
19961996-03-31	Free cash flow	483960	Operating Cash Flow: 2152105 Open source Capital Expenditure: 1668145 Open source
19971997-03-31	Free cash flow	437389	Operating Cash Flow: 2047116 Open source Capital Expenditure: 1609727 Open source

Balance sheet

Liabilities and short-term ability to meet obligations at each period end.

Liabilities to assets

Total liabilities as a share of total assets.

Not enough comparable data to show this history.

Values and sources

Liabilities to assets values and source evidence
Period	Series	Value	Source evidence
1993-03-31	Liabilities / assets	Not reported	No source recorded
1994-03-31	Liabilities / assets	Not reported	Total Assets: 18030293 Open source
1995-03-31	Liabilities / assets	Not reported	Total Assets: 18383908 Open source
1996-03-31	Liabilities / assets	Not reported	Total Assets: 18425700 Open source
1997-03-31	Liabilities / assets	Not reported	Total Assets: 19869527 Open source

Current assets to current liabilities

Current assets divided by current liabilities.

8.68× 1997

Values and sources

Current assets to current liabilities values and source evidence
Period	Series	Value	Source evidence
1993-03-31	Current assets / current liabilities	Not reported	No source recorded
19941994-03-31	Current assets / current liabilities	8.28×	Current Assets: 12807251 Open source Current Liabilities: 1546624 Open source
19951995-03-31	Current assets / current liabilities	7.48×	Current Assets: 12323544 Open source Current Liabilities: 1648369 Open source
19961996-03-31	Current assets / current liabilities	11.92×	Current Assets: 11241899 Open source Current Liabilities: 942917 Open source
19971997-03-31	Current assets / current liabilities	8.68×	Current Assets: 11491257 Open source Current Liabilities: 1323800 Open source

Cash generation

Compare reported profit with operating cash and capital spending. Free cash flow is calculated as operating cash flow minus capital expenditure when both exact, consolidated amounts match the same period and unit.

Cash generation by annual reporting period
Period	Net income	Operating cash flow	Capital expenditure	Free cash flow
1993 1992-04-01 – 1993-03-31	−USD 904,394 Exact value Exact value: -904394 USD 1992-04-01 – 1993-03-31: -904394 USD Inspect Net Income Open source Share or cite Citation for Net Income · GAMMA BIOLOGICALS INC · 1993-03-31 GAMMA BIOLOGICALS INC (edgar:317890) Net Income: -904394 USD Concept: fundies:NetIncome Period: 1992-04-01 to 1993-03-31 Values: Latest reported Published: 2026-11-06T13:21:10Z Snapshot: c1c1c7a2e9c234c9f8eeddae5dc416c4f05ba55f551639e1bb89a8556b1eaaa8 Dimensions: Consolidated View: https://fundies.io/companies/edgar/317890/explain?concept=fundies%3ANetIncome&period=1993-03-31&surface=latest&period_type=duration&start=1992-04-01&unit=USD&dimensions= Input fundies:NetIncome: -904394 USD (1992-04-01 to 1993-03-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/317890/0000899243-95-000398.txt#2373 The citation records this snapshot. The page link may show a newer release later.	USD 1.05 million Exact value Exact value: 1048508 USD 1992-04-01 – 1993-03-31: 1048508 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · GAMMA BIOLOGICALS INC · 1993-03-31 GAMMA BIOLOGICALS INC (edgar:317890) Operating Cash Flow: 1048508 USD Concept: fundies:OperatingCashFlow Period: 1992-04-01 to 1993-03-31 Values: Latest reported Published: 2026-11-06T13:21:10Z Snapshot: c1c1c7a2e9c234c9f8eeddae5dc416c4f05ba55f551639e1bb89a8556b1eaaa8 Dimensions: Consolidated View: https://fundies.io/companies/edgar/317890/explain?concept=fundies%3AOperatingCashFlow&period=1993-03-31&surface=latest&period_type=duration&start=1992-04-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: 1048508 USD (1992-04-01 to 1993-03-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/317890/0000899243-95-000398.txt#2385 The citation records this snapshot. The page link may show a newer release later.	USD 271,672 Exact value Exact value: 271672 USD 1992-04-01 – 1993-03-31: 271672 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · GAMMA BIOLOGICALS INC · 1993-03-31 GAMMA BIOLOGICALS INC (edgar:317890) Capital Expenditure: 271672 USD Concept: fundies:CapitalExpenditure Period: 1992-04-01 to 1993-03-31 Values: Latest reported Published: 2026-11-06T13:21:10Z Snapshot: c1c1c7a2e9c234c9f8eeddae5dc416c4f05ba55f551639e1bb89a8556b1eaaa8 Dimensions: Consolidated View: https://fundies.io/companies/edgar/317890/explain?concept=fundies%3ACapitalExpenditure&period=1993-03-31&surface=latest&period_type=duration&start=1992-04-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 271672 USD (1992-04-01 to 1993-03-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/317890/0000899243-95-000398.txt#2339 The citation records this snapshot. The page link may show a newer release later.	USD 776,836 Calculation and evidence 1048508 − 271672 USD Exact free cash flow: 776836 USD 1992-04-01 – 1993-03-31: 1048508 USD · Inspect Operating Cash Flow · Source 1992-04-01 – 1993-03-31: 271672 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · GAMMA BIOLOGICALS INC · 1993-03-31 GAMMA BIOLOGICALS INC (edgar:317890) Free cash flow: 776836 USD Concept: free-cash-flow Period: 1992-04-01 to 1993-03-31 Values: Latest reported Published: 2026-11-06T13:21:10Z Snapshot: c1c1c7a2e9c234c9f8eeddae5dc416c4f05ba55f551639e1bb89a8556b1eaaa8 Dimensions: Consolidated View: https://fundies.io/companies/edgar/317890?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: 1048508 USD (1992-04-01 to 1993-03-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/317890/0000899243-95-000398.txt#2385 Input fundies:CapitalExpenditure: 271672 USD (1992-04-01 to 1993-03-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/317890/0000899243-95-000398.txt#2339 The citation records this snapshot. The page link may show a newer release later.
1994 1993-04-01 – 1994-03-31	USD 1.35 million Exact value Exact value: 1348548 USD 1993-04-01 – 1994-03-31: 1348548 USD Inspect Net Income Open source Share or cite Citation for Net Income · GAMMA BIOLOGICALS INC · 1994-03-31 GAMMA BIOLOGICALS INC (edgar:317890) Net Income: 1348548 USD Concept: fundies:NetIncome Period: 1993-04-01 to 1994-03-31 Values: Latest reported Published: 2026-11-06T13:21:10Z Snapshot: c1c1c7a2e9c234c9f8eeddae5dc416c4f05ba55f551639e1bb89a8556b1eaaa8 Dimensions: Consolidated View: https://fundies.io/companies/edgar/317890/explain?concept=fundies%3ANetIncome&period=1994-03-31&surface=latest&period_type=duration&start=1993-04-01&unit=USD&dimensions= Input fundies:NetIncome: 1348548 USD (1993-04-01 to 1994-03-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/317890/0000899243-96-000802.txt#4623 The citation records this snapshot. The page link may show a newer release later.	USD 2.45 million Exact value Exact value: 2453912 USD 1993-04-01 – 1994-03-31: 2453912 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · GAMMA BIOLOGICALS INC · 1994-03-31 GAMMA BIOLOGICALS INC (edgar:317890) Operating Cash Flow: 2453912 USD Concept: fundies:OperatingCashFlow Period: 1993-04-01 to 1994-03-31 Values: Latest reported Published: 2026-11-06T13:21:10Z Snapshot: c1c1c7a2e9c234c9f8eeddae5dc416c4f05ba55f551639e1bb89a8556b1eaaa8 Dimensions: Consolidated View: https://fundies.io/companies/edgar/317890/explain?concept=fundies%3AOperatingCashFlow&period=1994-03-31&surface=latest&period_type=duration&start=1993-04-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: 2453912 USD (1993-04-01 to 1994-03-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/317890/0000899243-96-000802.txt#4633 The citation records this snapshot. The page link may show a newer release later.	USD 378,571 Exact value Exact value: 378571 USD 1993-04-01 – 1994-03-31: 378571 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · GAMMA BIOLOGICALS INC · 1994-03-31 GAMMA BIOLOGICALS INC (edgar:317890) Capital Expenditure: 378571 USD Concept: fundies:CapitalExpenditure Period: 1993-04-01 to 1994-03-31 Values: Latest reported Published: 2026-11-06T13:21:10Z Snapshot: c1c1c7a2e9c234c9f8eeddae5dc416c4f05ba55f551639e1bb89a8556b1eaaa8 Dimensions: Consolidated View: https://fundies.io/companies/edgar/317890/explain?concept=fundies%3ACapitalExpenditure&period=1994-03-31&surface=latest&period_type=duration&start=1993-04-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 378571 USD (1993-04-01 to 1994-03-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/317890/0000899243-96-000802.txt#4595 The citation records this snapshot. The page link may show a newer release later.	USD 2.08 million Calculation and evidence 2453912 − 378571 USD Exact free cash flow: 2075341 USD 1993-04-01 – 1994-03-31: 2453912 USD · Inspect Operating Cash Flow · Source 1993-04-01 – 1994-03-31: 378571 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · GAMMA BIOLOGICALS INC · 1994-03-31 GAMMA BIOLOGICALS INC (edgar:317890) Free cash flow: 2075341 USD Concept: free-cash-flow Period: 1993-04-01 to 1994-03-31 Values: Latest reported Published: 2026-11-06T13:21:10Z Snapshot: c1c1c7a2e9c234c9f8eeddae5dc416c4f05ba55f551639e1bb89a8556b1eaaa8 Dimensions: Consolidated View: https://fundies.io/companies/edgar/317890?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: 2453912 USD (1993-04-01 to 1994-03-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/317890/0000899243-96-000802.txt#4633 Input fundies:CapitalExpenditure: 378571 USD (1993-04-01 to 1994-03-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/317890/0000899243-96-000802.txt#4595 The citation records this snapshot. The page link may show a newer release later.
1995 1994-04-01 – 1995-03-31	USD 1.47 million Exact value Exact value: 1466519 USD 1994-04-01 – 1995-03-31: 1466519 USD Inspect Net Income Open source Share or cite Citation for Net Income · GAMMA BIOLOGICALS INC · 1995-03-31 GAMMA BIOLOGICALS INC (edgar:317890) Net Income: 1466519 USD Concept: fundies:NetIncome Period: 1994-04-01 to 1995-03-31 Values: Latest reported Published: 2026-11-06T13:21:10Z Snapshot: c1c1c7a2e9c234c9f8eeddae5dc416c4f05ba55f551639e1bb89a8556b1eaaa8 Dimensions: Consolidated View: https://fundies.io/companies/edgar/317890/explain?concept=fundies%3ANetIncome&period=1995-03-31&surface=latest&period_type=duration&start=1994-04-01&unit=USD&dimensions= Input fundies:NetIncome: 1466519 USD (1994-04-01 to 1995-03-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/317890/0000899243-97-001217.txt#4817 The citation records this snapshot. The page link may show a newer release later.	USD 770,013 Exact value Exact value: 770013 USD 1994-04-01 – 1995-03-31: 770013 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · GAMMA BIOLOGICALS INC · 1995-03-31 GAMMA BIOLOGICALS INC (edgar:317890) Operating Cash Flow: 770013 USD Concept: fundies:OperatingCashFlow Period: 1994-04-01 to 1995-03-31 Values: Latest reported Published: 2026-11-06T13:21:10Z Snapshot: c1c1c7a2e9c234c9f8eeddae5dc416c4f05ba55f551639e1bb89a8556b1eaaa8 Dimensions: Consolidated View: https://fundies.io/companies/edgar/317890/explain?concept=fundies%3AOperatingCashFlow&period=1995-03-31&surface=latest&period_type=duration&start=1994-04-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: 770013 USD (1994-04-01 to 1995-03-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/317890/0000899243-97-001217.txt#4826 The citation records this snapshot. The page link may show a newer release later.	USD 1.3 million Exact value Exact value: 1302629 USD 1994-04-01 – 1995-03-31: 1302629 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · GAMMA BIOLOGICALS INC · 1995-03-31 GAMMA BIOLOGICALS INC (edgar:317890) Capital Expenditure: 1302629 USD Concept: fundies:CapitalExpenditure Period: 1994-04-01 to 1995-03-31 Values: Latest reported Published: 2026-11-06T13:21:10Z Snapshot: c1c1c7a2e9c234c9f8eeddae5dc416c4f05ba55f551639e1bb89a8556b1eaaa8 Dimensions: Consolidated View: https://fundies.io/companies/edgar/317890/explain?concept=fundies%3ACapitalExpenditure&period=1995-03-31&surface=latest&period_type=duration&start=1994-04-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 1302629 USD (1994-04-01 to 1995-03-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/317890/0000899243-97-001217.txt#4788 The citation records this snapshot. The page link may show a newer release later.	−USD 532,616 Calculation and evidence 770013 − 1302629 USD Exact free cash flow: -532616 USD 1994-04-01 – 1995-03-31: 770013 USD · Inspect Operating Cash Flow · Source 1994-04-01 – 1995-03-31: 1302629 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · GAMMA BIOLOGICALS INC · 1995-03-31 GAMMA BIOLOGICALS INC (edgar:317890) Free cash flow: -532616 USD Concept: free-cash-flow Period: 1994-04-01 to 1995-03-31 Values: Latest reported Published: 2026-11-06T13:21:10Z Snapshot: c1c1c7a2e9c234c9f8eeddae5dc416c4f05ba55f551639e1bb89a8556b1eaaa8 Dimensions: Consolidated View: https://fundies.io/companies/edgar/317890?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: 770013 USD (1994-04-01 to 1995-03-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/317890/0000899243-97-001217.txt#4826 Input fundies:CapitalExpenditure: 1302629 USD (1994-04-01 to 1995-03-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/317890/0000899243-97-001217.txt#4788 The citation records this snapshot. The page link may show a newer release later.
1996 1995-04-01 – 1996-03-31	USD 823,530 Exact value Exact value: 823530 USD 1995-04-01 – 1996-03-31: 823530 USD Inspect Net Income Open source Share or cite Citation for Net Income · GAMMA BIOLOGICALS INC · 1996-03-31 GAMMA BIOLOGICALS INC (edgar:317890) Net Income: 823530 USD Concept: fundies:NetIncome Period: 1995-04-01 to 1996-03-31 Values: Latest reported Published: 2026-11-06T13:21:10Z Snapshot: c1c1c7a2e9c234c9f8eeddae5dc416c4f05ba55f551639e1bb89a8556b1eaaa8 Dimensions: Consolidated View: https://fundies.io/companies/edgar/317890/explain?concept=fundies%3ANetIncome&period=1996-03-31&surface=latest&period_type=duration&start=1995-04-01&unit=USD&dimensions= Input fundies:NetIncome: 823530 USD (1995-04-01 to 1996-03-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/317890/0001047469-98-025756.txt#2202 The citation records this snapshot. The page link may show a newer release later.	USD 2.15 million Exact value Exact value: 2152105 USD 1995-04-01 – 1996-03-31: 2152105 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · GAMMA BIOLOGICALS INC · 1996-03-31 GAMMA BIOLOGICALS INC (edgar:317890) Operating Cash Flow: 2152105 USD Concept: fundies:OperatingCashFlow Period: 1995-04-01 to 1996-03-31 Values: Latest reported Published: 2026-11-06T13:21:10Z Snapshot: c1c1c7a2e9c234c9f8eeddae5dc416c4f05ba55f551639e1bb89a8556b1eaaa8 Dimensions: Consolidated View: https://fundies.io/companies/edgar/317890/explain?concept=fundies%3AOperatingCashFlow&period=1996-03-31&surface=latest&period_type=duration&start=1995-04-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: 2152105 USD (1995-04-01 to 1996-03-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/317890/0001047469-98-025756.txt#2212 The citation records this snapshot. The page link may show a newer release later.	USD 1.67 million Exact value Exact value: 1668145 USD 1995-04-01 – 1996-03-31: 1668145 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · GAMMA BIOLOGICALS INC · 1996-03-31 GAMMA BIOLOGICALS INC (edgar:317890) Capital Expenditure: 1668145 USD Concept: fundies:CapitalExpenditure Period: 1995-04-01 to 1996-03-31 Values: Latest reported Published: 2026-11-06T13:21:10Z Snapshot: c1c1c7a2e9c234c9f8eeddae5dc416c4f05ba55f551639e1bb89a8556b1eaaa8 Dimensions: Consolidated View: https://fundies.io/companies/edgar/317890/explain?concept=fundies%3ACapitalExpenditure&period=1996-03-31&surface=latest&period_type=duration&start=1995-04-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 1668145 USD (1995-04-01 to 1996-03-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/317890/0001047469-98-025756.txt#2172 The citation records this snapshot. The page link may show a newer release later.	USD 483,960 Calculation and evidence 2152105 − 1668145 USD Exact free cash flow: 483960 USD 1995-04-01 – 1996-03-31: 2152105 USD · Inspect Operating Cash Flow · Source 1995-04-01 – 1996-03-31: 1668145 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · GAMMA BIOLOGICALS INC · 1996-03-31 GAMMA BIOLOGICALS INC (edgar:317890) Free cash flow: 483960 USD Concept: free-cash-flow Period: 1995-04-01 to 1996-03-31 Values: Latest reported Published: 2026-11-06T13:21:10Z Snapshot: c1c1c7a2e9c234c9f8eeddae5dc416c4f05ba55f551639e1bb89a8556b1eaaa8 Dimensions: Consolidated View: https://fundies.io/companies/edgar/317890?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: 2152105 USD (1995-04-01 to 1996-03-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/317890/0001047469-98-025756.txt#2212 Input fundies:CapitalExpenditure: 1668145 USD (1995-04-01 to 1996-03-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/317890/0001047469-98-025756.txt#2172 The citation records this snapshot. The page link may show a newer release later.
1997 1996-04-01 – 1997-03-31	USD 1.12 million Exact value Exact value: 1115820 USD 1996-04-01 – 1997-03-31: 1115820 USD Inspect Net Income Open source Share or cite Citation for Net Income · GAMMA BIOLOGICALS INC · 1997-03-31 GAMMA BIOLOGICALS INC (edgar:317890) Net Income: 1115820 USD Concept: fundies:NetIncome Period: 1996-04-01 to 1997-03-31 Values: Latest reported Published: 2026-11-06T13:21:10Z Snapshot: c1c1c7a2e9c234c9f8eeddae5dc416c4f05ba55f551639e1bb89a8556b1eaaa8 Dimensions: Consolidated View: https://fundies.io/companies/edgar/317890/explain?concept=fundies%3ANetIncome&period=1997-03-31&surface=latest&period_type=duration&start=1996-04-01&unit=USD&dimensions= Input fundies:NetIncome: 1115820 USD (1996-04-01 to 1997-03-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/317890/0001047469-98-025756.txt#2202 The citation records this snapshot. The page link may show a newer release later.	USD 2.05 million Exact value Exact value: 2047116 USD 1996-04-01 – 1997-03-31: 2047116 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · GAMMA BIOLOGICALS INC · 1997-03-31 GAMMA BIOLOGICALS INC (edgar:317890) Operating Cash Flow: 2047116 USD Concept: fundies:OperatingCashFlow Period: 1996-04-01 to 1997-03-31 Values: Latest reported Published: 2026-11-06T13:21:10Z Snapshot: c1c1c7a2e9c234c9f8eeddae5dc416c4f05ba55f551639e1bb89a8556b1eaaa8 Dimensions: Consolidated View: https://fundies.io/companies/edgar/317890/explain?concept=fundies%3AOperatingCashFlow&period=1997-03-31&surface=latest&period_type=duration&start=1996-04-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: 2047116 USD (1996-04-01 to 1997-03-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/317890/0001047469-98-025756.txt#2212 The citation records this snapshot. The page link may show a newer release later.	USD 1.61 million Exact value Exact value: 1609727 USD 1996-04-01 – 1997-03-31: 1609727 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · GAMMA BIOLOGICALS INC · 1997-03-31 GAMMA BIOLOGICALS INC (edgar:317890) Capital Expenditure: 1609727 USD Concept: fundies:CapitalExpenditure Period: 1996-04-01 to 1997-03-31 Values: Latest reported Published: 2026-11-06T13:21:10Z Snapshot: c1c1c7a2e9c234c9f8eeddae5dc416c4f05ba55f551639e1bb89a8556b1eaaa8 Dimensions: Consolidated View: https://fundies.io/companies/edgar/317890/explain?concept=fundies%3ACapitalExpenditure&period=1997-03-31&surface=latest&period_type=duration&start=1996-04-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 1609727 USD (1996-04-01 to 1997-03-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/317890/0001047469-98-025756.txt#2172 The citation records this snapshot. The page link may show a newer release later.	USD 437,389 Calculation and evidence 2047116 − 1609727 USD Exact free cash flow: 437389 USD 1996-04-01 – 1997-03-31: 2047116 USD · Inspect Operating Cash Flow · Source 1996-04-01 – 1997-03-31: 1609727 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · GAMMA BIOLOGICALS INC · 1997-03-31 GAMMA BIOLOGICALS INC (edgar:317890) Free cash flow: 437389 USD Concept: free-cash-flow Period: 1996-04-01 to 1997-03-31 Values: Latest reported Published: 2026-11-06T13:21:10Z Snapshot: c1c1c7a2e9c234c9f8eeddae5dc416c4f05ba55f551639e1bb89a8556b1eaaa8 Dimensions: Consolidated View: https://fundies.io/companies/edgar/317890?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: 2047116 USD (1996-04-01 to 1997-03-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/317890/0001047469-98-025756.txt#2212 Input fundies:CapitalExpenditure: 1609727 USD (1996-04-01 to 1997-03-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/317890/0001047469-98-025756.txt#2172 The citation records this snapshot. The page link may show a newer release later.

Capital expenditure uses the canonical mapped positive-spending convention. A missing, ambiguous, incompatible, or negative-sign input is left blank. Values use the latest reported version.

Dataset coverage and company identifiers

Coverage reflects filings processed into this Fundies dataset; it does not imply every source filing is loaded.

14 filings · 0 latest values · 0 originally reported values

Dataset published 2026-11-06. Source filing dates and reporting periods are shown separately.

Identifiers: 0000317890, 317890, edgar:317890

GAMMA BIOLOGICALS INC

Latest quarter

Revenue

Operating margin

Operating cash flow

Free cash flow

Trailing twelve months

Net income

Operating cash flow

Capital expenditure

Free cash flow

Company performance

What changed year over year

Revenue

Net income

Operating cash flow

Capital expenditure

Where revenue goes

1997 1996-04-01 – 1997-03-31

Cash

Share of revenue by period

Growth

Profit and cash

Balance sheet

Cash generation